March 19, 2009 (FinancialWire) -- Exact Sciences Corp.'s (NASDAQ: EXAS) (Current Market Cap: US$22.62 Mil.) board of directors has appointed Kevin T. Conroy as president and chief executive, and Maneesh K. Arora as senior vice president and chief financial officer, effective April 2. Conroy is joining the company's board immediately.

Conroy and Arora were most recently president and chief executive, and chief financial officer, respectively, of Third Wave Technologies, a molecular diagnostics company that was acquired last year by Hologic for $582 million.

During Conroy's tenure as chief executive of Third Wave, he oversaw the development of two human papillomavirus molecular diagnostic tests, including their clinical trial. Both of the Third-Wave-developed HPV tests received U.S. Food and Drug Administration approval last week.

Conroy also led Third Wave through the clinical trial of its InPlex cystic fibrosis test, which received FDA clearance in March 2008.

Arora was appointed CFO of Third Wave in January 2006. He joined the company in January 2003 as director of strategy and was promoted successively to vice president and senior vice president in 2004. Prior to joining Third Wave, Arora was director of corporate strategy for Nalco Chemical.

Marlborough, Massachusetts-based Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer.

FinancialWire" ( http://www.financialwire.net ), an independent, proprietary news service of Investrend Communications, Inc., receives no compensation for its news or opinions. Further disclosure is at http://www.investrend.com/articles/secondlevel.asp?level=472 . To contact FinancialWire" write to inquiries@financialwire.net .

Free annual reports for companies mentioned in the news are accessible via http://investrend.ar.wilink.com/?level=279 .

Copyright(C)2009 by financialwire.net, Inc. All rights reserved.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.